Recent News

• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.08.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 08.26.2025 - Compass Therapeutics to Participate in Upcoming September Investor Events
• 08.26.2025 - Compass Therapeutics to Participate in Upcoming September Investor Events
• 08.13.2025 - Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
• 08.13.2025 - Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering
• 08.12.2025 - Compass Therapeutics Announces Proposed Public Offering
• 08.12.2025 - Compass Therapeutics Announces Proposed Public Offering

Recent Filings

• 08.21.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.18.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.15.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 8-K Current report